Status:
COMPLETED
Optimizing Left Ventricular Lead To Improve Cardiac Output
Lead Sponsor:
Ann Marie Chikowski
Collaborating Sponsors:
Main Line Health
Conditions:
Ischemic Congestive Cardiomyopathy
Dilated Cardiomyopathy
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study is to determine if optimal lead placement, guided by the largest improvement in aortic flow measured by Doppler will: 1. Improve the way the heart's left ventricle functions...
Detailed Description
The hypothesis of this study determines if response to CRT therapy could be improved by optimizing LV lead position at the time of the left ventricular pacing lead implantation. This optimization (usi...
Eligibility Criteria
Inclusion
- Clinical indication for CRT-P or CRT-D
- QRS Duration\>=120 MSEC
- Left Ventricular Ejection fraction\<=35%
- NYHA Class III-IV
- History of Cardiomyopathy, least one month post MI, or at least six months old in case of non-ischemic cardiomyopathy
- At least 18 years of afe
Exclusion
- Previous implanted CRT-P/CRT-D
- woman who are pregnant
- Psychological or emotional problems
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 25 2014
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01399801
Start Date
December 1 2010
End Date
September 25 2014
Last Update
August 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lankenau Hosspital
Wynnewood, Pennsylvania, United States, 19096